These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 460262)

  • 21. Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis.
    Underwood BA; Denning CR; Navab M
    Ann N Y Acad Sci; 1972 Dec; 203():237-47. PubMed ID: 4512105
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis.
    Strandvik B; Hultcrantz R
    Liver; 1994 Feb; 14(1):32-6. PubMed ID: 8177027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fatty acid pattern in children with mucoviscidosis in relation to the degree of exocrine pancreas insufficiency].
    Henker J; Schimke E; Paul KD; Leupold W
    Helv Paediatr Acta; 1987 Jun; 42(1):13-20. PubMed ID: 3667328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
    Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
    Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis.
    Valletta EA; Rigo A; Bonazzi L; Zanolla L; Mastella G
    Acta Univ Carol Med (Praha); 1990; 36(1-4):44-5. PubMed ID: 2130717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressed plasma retinol-binding protein levels in cystic fibrosis.
    Smith FR; Underwood BA; Denning CR; Varma A; Goodman DS
    J Lab Clin Med; 1972 Sep; 80(3):423-33. PubMed ID: 5055389
    [No Abstract]   [Full Text] [Related]  

  • 27. Postprandial total serum bile acid concentrations in cystic fibrosis.
    Starkey BJ; Goodchild MC
    Monogr Paediatr; 1979; 10():12-8. PubMed ID: 460266
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect on renal function of essential fatty acid supplementation in cystic fibrosis.
    Strandvik B; Berg U; Kallner A; Kusoffsky E
    J Pediatr; 1989 Aug; 115(2):242-50. PubMed ID: 2754552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
    Van Biervliet S; Devos M; Delhaye T; Van Biervliet JP; Robberecht E; Christophe A
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):109-15. PubMed ID: 18276127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycosides lower serum magnesium concentrations in patients with cystic fibrosis: a retrospective study.
    Holben DH; Smith AM; Wilmott RW
    J Am Diet Assoc; 1995 Oct; 95(10):1152-4. PubMed ID: 7560688
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology.
    Driscoll DF; Bistrian BR; Demmelmair H; Koletzko B
    Clin Nutr; 2008 Aug; 27(4):497-503. PubMed ID: 18582994
    [No Abstract]   [Full Text] [Related]  

  • 32. American Academy of Pediatrics. Committee on Nutrition. Use of Intravenous fat emulsions in pediatric patients.
    Pediatrics; 1981 Nov; 68(5):738-43. PubMed ID: 6796933
    [No Abstract]   [Full Text] [Related]  

  • 33. [Behavior of the serum fatty acid patterns during administration of an MCT-containing fat emulsion].
    Sailer D; Berg G
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):171-4. PubMed ID: 572340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of lipids in total parenteral nutrition].
    Motton G; Burro A
    Chir Ital; 1994; 46(6):31-5. PubMed ID: 8521538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis.
    Hubbard VS; Dunn GD
    Clin Chim Acta; 1980 Mar; 102(1):115-8. PubMed ID: 7389104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute priapism after infusion of 10% fat emulsion in a child with cystic fibrosis].
    Douchain F; Hode E; Paul JC; Bakhache P; Pautard JC
    Presse Med; 1990 Mar; 19(9):429. PubMed ID: 2138768
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatty acid pattern of platelet phospholipids in cystic fibrosis.
    Rogiers V; Vercruysse A; Dab I; Crokaert R; Vis HL
    Eur J Pediatr; 1984 Sep; 142(4):305-6. PubMed ID: 6489383
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis.
    Kusoffsky E; Strandvik B; Troell S
    J Pediatr Gastroenterol Nutr; 1983; 2(3):434-8. PubMed ID: 6413667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional supplementation for cystic fibrosis.
    Shepherd RW
    J Pediatr; 1986 Jun; 108(6):1037-9. PubMed ID: 3086529
    [No Abstract]   [Full Text] [Related]  

  • 40. Essential fatty acids in cystic fibrosis.
    Rosenlund ML; Kim HK; Kritchevsky D
    Nature; 1974 Oct; 251(5477):719. PubMed ID: 4427669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.